Metformin use and respiratory outcomes in asthma-COPD overlap
Metformin use and respiratory outcomes in asthma-COPD overlap
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
Metformin is associated with improved respiratory outcomes in asthma; however, metformin in COPD and asthma-COPD overlap (ACO) remains unexplored.
To determine the association between metformin use and respiratory outcomes in COPD and ACO.
Participants with COPD (FEV1/FVC < 0.70) in the Genetic Epidemiology of COPD study (COPDGene®) were cate...
Alternative Titles
Full title
Metformin use and respiratory outcomes in asthma-COPD overlap
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ea3dc023778b43ee9d438ced6d2a7065
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ea3dc023778b43ee9d438ced6d2a7065
Other Identifiers
ISSN
1465-993X,1465-9921
E-ISSN
1465-993X,1465-9921
DOI
10.1186/s12931-021-01658-3
